Farther Finance Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$191K	Sell	8,395 -922	-10%	-$20.5K	﹤0.01%	2049
2025 Q4	$241K	Buy	9,317 +1,145	+14%	+$27.2K	﹤0.01%	1798
2025 Q3	$211K	Buy	8,172 +12	+0.1%	+$295	﹤0.01%	1578
2025 Q2	$195K	Buy	8,160 +7,651	+1,503%	+$193K	﹤0.01%	1403
2025 Q1	$12.3K	Buy	+509	New	+$12.2K	﹤0.01%	2642
2024 Q4	–	Sell	-8	Closed	-$120	–	4114
2024 Q3	$120	Sell	8 -22	-73%	-$376	﹤0.01%	3747
2024 Q2	$854	Buy	30 +26	+650%	+$740	﹤0.01%	3123
2024 Q1	$117	Sell	4 -38	-90%	-$1.17K	﹤0.01%	3355
2023 Q4	$1.42K	Buy	42 +37	+740%	+$1.08K	﹤0.01%	2579
2023 Q3	$153	Buy	+5	New	+$180	﹤0.01%	2504
2023 Q2	–	Sell	-15	Closed	-$612	–	2551
2023 Q1	$612	Buy	+15	New	+$597	﹤0.01%	1955